How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons

In this episode of the Oncology Brothers podcast, Drs. Rohit and Rahul Gosain welcome Dr. Sarah Sammons from Dana-Farber Cancer Institute to discuss the treatment landscape for HER2-positive breast cancer. Building on their previous discussions about triple-negative breast cancer, Drs. Gosain and Sammons dive deep into the treatment algorithms for early-stage, locally advanced, and metastatic HER2-positive breast cancer.

Key topics include:
•⁠  ⁠Treatment paradigms for early-stage HER2-positive breast cancer, including the APT trial and considerations for neoadjuvant therapy.
•⁠  ⁠The standard of care for locally advanced disease with TCHP and managing associated toxicities.
•⁠  ⁠Insights into the latest data from the PATINA trial and its implications for metastatic HER2-positive patients.
•⁠  ⁠Discussion on the use of T-DXd and other treatment options in the second and third-line settings, especially for patients with brain metastases.

Join us for an informative conversation filled with clinical pearls and practical insights that can help guide treatment decisions in HER2-positive breast cancer. Don't forget to like, subscribe, and check out our other episodes in the treatment algorithm series!
#OncologyBrothers #HER2Positive #BreastCancer #BreastCancerTreatment #CancerPodcast #DanaFarber

YouTube: https://youtu.be/_y0xSxJTptw

Follow us on social media:
•⁠  ⁠X/Twitter: https://twitter.com/oncbrothers
•⁠  ⁠Instagram: https://www.instagram.com/oncbrothers